Universal Health Services Stock (NYSE: UHS)

Dernières nouvelles pour Universal Health Services (NYSE:UHS) Stock

UNIVERSAL HEALTH SERVICES-B

Universal Health Services

Universal Health Servs

Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.

Universal Health Services, Inc. Common Stock

Universal Health Services Inc

Barclays analyst Andrew Mok maintains Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Overweight and raises the price target from $257 to $259.

News

Price Target

Analyst Ratings

Barclays Maintains Overweight on Universal Health Services, Raises Price Target to $259

WIIM

Universal Health Services shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 adjusted EPS guidance above estimates.

Universal Health Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>), one of the largest healthcare management companies in the U.S., reported second-quarter adjusted earnings of $5.35 per share on Monday.
The company, which oversees hundreds of behavioral health facilities, beat <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">the consensus of $4.92</a>.
The King of Prussia, Pennsylvania-based hospital operator reported sales of $4.28 billion, up 9.6% year over year, beating the consensus estimate of $4.24 billion.
Also Read: <a href="https://www.benzinga.com/markets/earnings/25/07/46632096/hca-healthcare-eyes-76-billion-revenue-aggressive-profit-growth" target="_blank" rel="noreferrer noopener">HCA Healthcare Eyes $76 Billion Revenue, Aggressive Profit Growth</a>
<h2 class="wp-block-heading">Acute care hospitals</h2>
During the second quarter of 2025, at acute care hospitals owned during both periods (on the same facility basis), adjusted admissions (adjusted for outpatient activity) increased by 2.0%, while adjusted patient days <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46673559/universal-health-services-inc-announces-financial-results-for-the-three-and-six-month-periods-ende" rel="noreferrer noopener">increased by 1.1% year over year</a>.
Net revenue per adjusted admission increased by 3.8% while net revenue per adjusted patient day increased by 4.7%.
Net revenues generated from acute care services, on a same facility basis, increased by 7.9%.
<h2 class="wp-block-heading">Behavioral health care facilities</h2>
During the second quarter of 2025, at behavioral health care facilities on a same-facility basis, adjusted admissions increased by 0.4%, while adjusted patient days increased by 1.2%.
Net revenue per adjusted admission increased by 8.6% and net revenue per adjusted patient day increased by 7.8%.
Net revenues generated from behavioral health care services, on a same facility basis, increased by 8.9%.
Universal Health operates 29 inpatient acute care hospitals and 338 inpatient behavioral health facilities, plus 61 outpatient facilities.
<h2 class="wp-block-heading">Guidance</h2>
Universal Health Services raised fiscal year 2025 adjusted earnings from $18.45-$19.95&nbsp;per share to&nbsp;$20.00-$21.00, compared to the consensus of&nbsp;$19.68.
The company narrowed 2025 sales&nbsp;guidance&nbsp;from&nbsp;$17.02 billion-$17.36 billion to&nbsp;$17.09 billion-$17.31 billion, versus the consensus of&nbsp;$17.14 billion.
UHS revised its 2025 forecasted adjusted EBITDA to approximately&nbsp;$2.46 billion—$2.543 billion, compared to the prior range of $2.36 billion—$2.48 billion.
<h2 class="wp-block-heading">Analyst Take</h2>
Guggenheim Partners said adjusted EBITDA-NCI of $643 million beat the consensus estimate of $615 million. However, the company's underlying "core" performance was weaker than expected after removing $101 million in DPP payments not included in the original guidance and a $25 million added headwind from DC hospitals. The shortfall was mainly due to underperformance in the Behavioral segment.
Analyst Jason Cassorla writes, &#8220;However, we believe higher 2025 EBITDA and subsequently FCF likely translates into higher share repurchase, all-else equal, and that leverage at 1.9x gives the company ample flexibility to continue augmenting returns.&#8221;
Analyst Cassorla expects the stock to trade unevenly following the results, despite a ~15% drop in the past two weeks (compared to a 2% gain in the S&amp;P 500) and UHS trading at historically low valuation levels. Investors remain cautious about future growth in the behavioral health segment due to ongoing challenges in patient volumes.
Price Action: UHS stock is up 4.86% at $162.49&nbsp;at the last check on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46687002/ups-volume-takes-a-hit-on-tariff-induced-weakness-withholds-annual-outlook" target="_blank" rel="noreferrer noopener">UPS Volume Takes A Hit On Tariff-Induced Weakness, Withholds Annual Outlook</a></li>
</ul>
Image: Shutterstock

Analyst Color

Earnings

Guidance

Health Care

Movers

Trading Ideas

General

Behavioral Segment Concerns Overshadow Universal Health Q2 Earnings Beat

Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) raises FY2025 Adj EPS guidance from $18.45-$19.95 to $20.00-$21.00 vs $19.68 analyst estimate. Narrows FY2025 sales outlook from $17.020 billion-$17.364 billion to $17.096 billion-$17.312 billion vs $17.136 billion estimate.

Universal Health Services Raises FY2025 Adj EPS Guidance from $18.45-$19.95 to $20.00-$21.00 vs $19.68 Est; Narrows FY2025 Sales Guidance from $17.020B-$17.364B to $17.096B-$17.312B vs $17.136B Est

Universal Health Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) reported quarterly earnings of $5.35 per share which beat the analyst consensus estimate of $4.92 by 8.74 percent. This is a 24.13 percent increase over earnings of $4.31 per share from the same period last year. The company reported quarterly sales of $4.283 billion which beat the analyst consensus estimate of $4.239 billion by 1.04 percent. This is a 9.60 percent increase over sales of $3.908 billion the same period last year.

Earnings Beats

Universal Health Servs Q2 Adj. EPS $5.35 Beats $4.92 Estimate, Sales $4.283B Beat $4.239B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Bank of Hawaii (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) is likely to report quarterly earnings at $1.05 per share on revenue of $174.39 million. 
• Business First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $78.91 million. 
• Alliance Res Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARLP#NASDAQ">ARLP</a>) is projected to report quarterly earnings at $0.60 per share on revenue of $583.55 million. 
• Enterprise Prods Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) is expected to report quarterly earnings at $0.64 per share on revenue of $14.19 billion. 
• Rithm Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>) is estimated to report quarterly earnings at $0.52 per share on revenue of $1.17 billion. 
• New Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NGD#AMEX">NGD</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $319.96 million. 
• Alerus Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) is projected to report quarterly earnings at $0.55 per share on revenue of $69.95 million. 
• Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) is estimated to report quarterly earnings at $1.14 per share on revenue of $711.31 million. 
• Bank of Marin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRC#NASDAQ">BMRC</a>) is expected to report quarterly earnings at $0.35 per share on revenue of $26.77 million. 
• Fomento Economico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>) is estimated to report quarterly earnings at $0.91 per share on revenue of $11.18 billion. 
• Provident Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROV#NASDAQ">PROV</a>) is projected to report quarterly earnings at $0.30 per share on revenue of $10.40 million. 
• Bankwell Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWFG#NASDAQ">BWFG</a>) is expected to report quarterly earnings at $0.85 per share on revenue of $24.31 million. 
<h3>Companies Reporting After The Bell</h3>
• Brixmor Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRX#NYSE">BRX</a>) is estimated to report quarterly earnings at $0.35 per share on revenue of $331.31 million. 
• Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $2.49 billion. 
• TFI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) is projected to report quarterly earnings at $1.24 per share on revenue of $2.06 billion. 
• PotlatchDeltic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCH#NASDAQ">PCH</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $259.74 million. 
• NewtekOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) is estimated to report quarterly earnings at $0.51 per share on revenue of $74.22 million. 
• Bank of N.T Butterfield (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTB#NYSE">NTB</a>) is expected to report quarterly earnings at $1.19 per share on revenue of $144.84 million. 
• Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $577.73 million. 
• Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $2.67 billion. 
• Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) is projected to report quarterly earnings at $1.42 per share on revenue of $1.25 billion. 
• Pathward Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASH#NASDAQ">CASH</a>) is projected to report quarterly earnings at $1.63 per share on revenue of $185.55 million. 
• Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) is estimated to report quarterly earnings at $0.99 per share on revenue of $1.28 billion. 
• Ameris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABCB#NYSE">ABCB</a>) is estimated to report quarterly earnings at $1.34 per share on revenue of $298.12 million. 
• Telefonica Brasil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIV#NYSE">VIV</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $2.59 billion. 
• Two Harbors Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWO#NYSE">TWO</a>) is expected to report quarterly earnings at $0.31 per share on revenue of $-23 million. 
• NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) is estimated to report quarterly earnings at $0.30 per share on revenue of $2.15 billion. 
• Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) is likely to report quarterly earnings at $0.60 per share on revenue of $334.05 million. 
• Firstsun Capital Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSUN#NASDAQ">FSUN</a>) is estimated to report quarterly earnings at $0.90 per share on revenue of $103.34 million. 
• Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) is expected to report quarterly earnings at $1.34 per share on revenue of $568.53 million. 
• Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) is likely to report quarterly loss at $0.41 per share on revenue of $479 thousand. 
• UFP Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPI#NASDAQ">UFPI</a>) is estimated to report quarterly earnings at $1.89 per share on revenue of $1.85 billion. 
• Principal Financial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) is expected to report quarterly earnings at $1.98 per share on revenue of $3.99 billion. 
• Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) is projected to report quarterly earnings at $2.67 per share on revenue of $8.45 billion. 
• The Hartford Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) is estimated to report quarterly earnings at $2.81 per share on revenue of $6.17 billion. 
• CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) is likely to report quarterly earnings at $0.85 per share on revenue of $966.16 million. 
• Cincinnati Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CINF#NASDAQ">CINF</a>) is estimated to report quarterly earnings at $1.39 per share on revenue of $2.79 billion. 
• Northeast Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBN#NASDAQ">NBN</a>) is expected to report quarterly earnings at $2.57 per share on revenue of $56.06 million. 
• Western Union (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WU#NYSE">WU</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $1.04 billion. 
• Waste Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) is expected to report quarterly earnings at $1.89 per share on revenue of $6.35 billion. 
• Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) is projected to report quarterly earnings at $4.90 per share on revenue of $4.23 billion. 
• Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) is likely to report quarterly loss at $0.01 per share on revenue of $235.99 million. 
• Simpson Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) is expected to report quarterly earnings at $2.31 per share on revenue of $599.39 million. 
• Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) is projected to report quarterly earnings at $0.02 per share on revenue of $1.66 billion. 
• NBT Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBTB#NASDAQ">NBTB</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $170.78 million. 
• Kilroy Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) is likely to report quarterly earnings at $0.59 per share on revenue of $269.64 million. 
• H2O America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTO#NASDAQ">HTO</a>) is likely to report quarterly earnings at $0.71 per share on revenue of $185.70 million. 
• COPT Defense Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDP#NYSE">CDP</a>) is expected to report quarterly earnings at $0.46 per share on revenue of $184.31 million. 
• Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) is projected to report quarterly earnings at $0.16 per share on revenue of $1.42 billion. 
• Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) is likely to report quarterly earnings at $1.63 per share on revenue of $889.41 million. 
• Whirlpool (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) is likely to report quarterly earnings at $1.66 per share on revenue of $3.84 billion. 
• Veralto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLTO#NYSE">VLTO</a>) is projected to report quarterly earnings at $0.89 per share on revenue of $1.34 billion. 
• Sanmina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) is likely to report quarterly earnings at $1.31 per share on revenue of $1.98 billion. 
• Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) is projected to report quarterly loss at $1.20 per share on revenue of $4.44 million. 
• GBank Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBFH#NASDAQ">GBFH</a>) is likely to report quarterly earnings at $0.38 per share on revenue of $19.00 million. 
• Ranger Energy Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNGR#NYSE">RNGR</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $140.00 million. 
• Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $133.02 million. 
• Curbline Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURB#NYSE">CURB</a>) is estimated to report quarterly earnings at $0.16 per share on revenue of $37.95 million. 
• Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $501.10 million. 
• Seven Hills Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEVN#NASDAQ">SEVN</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $7.87 million. 
• Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) is estimated to report quarterly earnings at $0.50 per share on revenue of $166.98 million. 
• Piedmont Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDM#NYSE">PDM</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $141.91 million. 
• Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) is expected to report quarterly earnings at $1.10 per share on revenue of $160.32 million. 
• Enterprise Finl Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSC#NASDAQ">EFSC</a>) is projected to report quarterly earnings at $1.20 per share on revenue of $164.87 million. 
• Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) is expected to report quarterly loss at $0.36 per share on revenue of $254.77 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABCB

ALRS

AMKR

ARLP

BFST

BMRC

BWFG

BYON

CASH

CDNS

CINF

CURB

EFSC

EKSO

EXEL

Fomento Economico Mexicano S.A.B. De C.V.

FSUN

GBFH

GOVX

HLIT

KFRC

MBIN

NBTB

NEWT

PROV

RITM

RMBS

RNGR

RVTY

SANM

SEVN

TFII

TLRY

UCTT

UFPI

VLTO

WELL

Earnings Scheduled For July 28, 2025

Universal Health Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) is set to give its latest quarterly earnings report on Monday, 2025-07-28. Here's what investors need to know before the announcement.
Analysts estimate that Universal Health Servs will report an earnings per share (EPS) of $4.90. 
Investors in Universal Health Servs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat EPS by $0.50, which was followed by a 0.6% drop in the share price the next day.
Here's a look at Universal Health Servs's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>4.34</td>
<td>4.18</td>
<td>3.70</td>
<td>3.28</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>4.84</td>
<td>4.92</td>
<td>3.71</td>
<td>4.31</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>3.0%</td>
<td>-10.0%</td>
<td>10.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753452164_0.png" alt="eps graph" />
<h3>Market Performance of Universal Health Servs's Stock</h3>
Shares of Universal Health Servs were trading at $155.46 as of July 24. Over the last 52-week period, shares are down 28.51%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Insights Shared by Analysts on Universal Health Servs</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Universal Health Servs.
With 3 analyst ratings, Universal Health Servs has a consensus rating of Neutral. The average one-year price target is $214.33, indicating a potential 37.87% upside.
<h3>Analyzing Analyst Ratings Among Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Encompass Health, Ensign Group and Tenet Healthcare, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Encompass Health, with an average 1-year price target of $132.0, suggesting a potential 15.09% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Ensign Group, with an average 1-year price target of $156.0, suggesting a potential 0.35% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Tenet Healthcare, with an average 1-year price target of $194.65, suggesting a potential 25.21% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
The peer analysis summary outlines pivotal metrics for Encompass Health, Ensign Group and Tenet Healthcare, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Universal Health Services</td>
<td>Neutral</td>
<td>6.66%</td>
<td>$3.70B</td>
<td>4.71%</td>
</tr>
<tr>
<td>Encompass Health</td>
<td>Outperform</td>
<td>10.59%</td>
<td>$630.90M</td>
<td>7.17%</td>
</tr>
<tr>
<td>Ensign Group</td>
<td>Outperform</td>
<td>16.12%</td>
<td>$188.12M</td>
<td>4.27%</td>
</tr>
<tr>
<td>Tenet Healthcare</td>
<td>Outperform</td>
<td>0.92%</td>
<td>$4.32B</td>
<td>7.26%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Universal Health Services ranks in the middle for Consensus rating among its peers. It is at the bottom for Revenue Growth. It is at the top for Gross Profit. It is in the middle for Return on Equity.
<h3>Get to Know Universal Health Servs Better</h3>
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
<h3>Breaking Down Universal Health Servs's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Over the 3 months period, Universal Health Servs showcased positive performance, achieving a revenue growth rate of 6.66% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Universal Health Servs's net margin excels beyond industry benchmarks, reaching 7.72%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Universal Health Servs's ROE excels beyond industry benchmarks, reaching 4.71%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Universal Health Servs's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.16% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.75, Universal Health Servs adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/UHS/earnings">To track all earnings releases for Universal Health Servs visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What's Next: Universal Health Servs's Earnings Preview

Universal Health Services shares are trading lower after BofA Securities downgraded the stock from Neutral to Underperform and lowered its price target from $215 to $185.

B of A Securities analyst Kevin Fischbeck downgrades Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) from Neutral to Underperform and lowers the price target from $215 to $185.

Downgrades

B of A Securities Downgrades Universal Health Services to Underperform, Lowers Price Target to $185

Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) has outperformed the market over the past 20 years by 1.25% on an annualized basis producing an average annual return of 9.73%. Currently, Universal Health Services has a market capitalization of $11.86 billion. 
Buying $1000 In UHS: If an investor had bought $1000 of UHS stock 20 years ago, it would be worth $6,367.41 today based on a price of $184.05 for UHS at the time of writing.
<h3>Universal Health Services's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752178512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Universal Health Services's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) short percent of float has fallen 14.03% since its last report. The company recently reported that it has 2.15 million shares sold short, which is 5.33% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.57 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Universal Health Services Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750431654_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Universal Health Services has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Universal Health Services's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Universal Health Services's peer group average for short interest as a percentage of float is 4.95%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Universal Health Services?

<a href="https://www.wsj.com/livecoverage/stock-market-today-trump-tariffs-trade-war-06-09-2025/card/hospital-stocks-fall-after-new-trump-directive-on-medicaid-vAl1E69iscGQaix3k0tK" title="https://www.wsj.com/livecoverage/stock-market-today-trump-tariffs-trade-war-06-09-2025/card/hospital-stocks-fall-after-new-trump-directive-on-medicaid-vAl1E69iscGQaix3k0tK">https://www.wsj.com/livecoverage/stock-market-today-trump-tariffs-trade-war-06-09-2025/card/hospital-stocks-fall-after-new-trump-directive-on-medicaid-vAl1E69iscGQaix3k0tK</a>

'Hospital Stocks Fall After New Trump Directive on Medicaid' - WSJ

Shares of medical insurance and medical provider companies are trading lower after President Trump, on June 6, told the Department of Health and Human Services to eliminate waste, fraud and abuse in Medicaid.

Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) has outperformed the market over the past 20 years by 1.14% on an annualized basis producing an average annual return of 9.39%. Currently, Universal Health Services has a market capitalization of $11.96 billion. 
Buying $100 In UHS: If an investor had bought $100 of UHS stock 20 years ago, it would be worth $607.28 today based on a price of $185.65 for UHS at the time of writing.
<h3>Universal Health Services's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748879113_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

In the current market session, Universal Health Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) stock price is at $186.21, after a 0.24% drop. However, over the past month, the company's stock went up by 8.34%, and in the past year, by 6.30%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1748296816_0.png" alt="Past Year Chart" />

<h3>Universal Health Services P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Universal Health Services has a lower P/E than the aggregate P/E of 17.85 of the Health Care Providers &amp; Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748296816_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Universal Health Services

Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) has outperformed the market over the past 20 years by 1.61% on an annualized basis producing an average annual return of 9.94%. Currently, Universal Health Services has a market capitalization of $12.60 billion. 
Buying $100 In UHS: If an investor had bought $100 of UHS stock 20 years ago, it would be worth $665.00 today based on a price of $195.50 for UHS at the time of writing.
<h3>Universal Health Services's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747843229_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Universal Health Services 20 Years Ago Would Be Worth This Much Today

Universal Health Services's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) short percent of float has risen 4.66% since its last report. The company recently reported that it has 2.53 million shares sold short, which is 6.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.64 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Universal Health Services Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747314032_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Universal Health Services has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Universal Health Services's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Universal Health Services's peer group average for short interest as a percentage of float is 4.79%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What Does the Market Think About Universal Health Services?

RBC Capital analyst Ben Hendrix maintains Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Sector Perform and lowers the price target from $211 to $201.

RBC Capital Maintains Sector Perform on Universal Health Services, Lowers Price Target to $201

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $224.5, with a high estimate of $257.00 and a low estimate of $200.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 6.72%. 
<img src="https://www.benzinga.com/files/images/story/2025/1745949668_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Universal Health Services among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$257.00</td>
<td>$249.00</td>
</tr>
<tr>
<td>Michael Ha</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$224.00</td>
<td>$274.00</td>
</tr>
<tr>
<td>Jason Cassorla</td>
<td>Guggenheim</td>
<td>Announces</td>
<td>Buy</td>
<td>$208.00</td>
<td>-</td>
</tr>
<tr>
<td>Craig Hettenbach</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$200.00</td>
<td>-</td>
</tr>
<tr>
<td>Stephen Baxter</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$225.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Scott Fidel</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$223.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Raj Kumar</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$249.00</td>
<td>$271.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Universal Health Services. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Universal Health Services compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Universal Health Services's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Universal Health Services's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/UHS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Universal Health Services analyst ratings.</a>
<h2>Discovering Universal Health Services: A Closer Look</h2>
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
<h3>Universal Health Services's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Universal Health Services displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 11.08%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Universal Health Services's net margin is impressive, surpassing industry averages. With a net margin of 8.08%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Universal Health Services's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.01%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Universal Health Services's ROA stands out, surpassing industry averages. With an impressive ROA of 2.31%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Universal Health Services's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.74.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Universal Health Services Stands With Analysts

Barclays analyst Andrew Mok maintains Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Overweight and raises the price target from $249 to $257.

Barclays Maintains Overweight on Universal Health Services, Raises Price Target to $257

Press Releases

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT KEYBANC CAPITAL MARKETS VIRTUAL HEALTHCARE FORUM

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

Engine Capital Nominates Two Highly Qualified and Independent Candidates for Election to Lyft's Board of Directors at the 2025 Annual Meeting

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2025 FIRST QUARTER FINANCIAL RESULTS

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT HEALTHCARE CONFERENCES

Dividends

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES TIME CHANGE  FOR SECOND QUARTER 2025 EARNINGS CONFERENCE CALL

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2025, AND INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST

Comments

Universal Health Services

Actualités

Dernières nouvelles pour Universal Health Services (NYSE:UHS) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL